-
公开(公告)号：WO2010062122A2
公开(公告)日：2010-06-03
申请号：PCT/KR2009/007010
申请日：2009-11-26
CPC classification number: A61K36/258
Abstract: 본 발명에 따른 조성물은 인삼(Panax ginseng C.A. Meyer) 열매의 추출물을 유효성분으로 함유하는 동맥경화 예방 또는 치료용 조성물로서, 상기 인삼 열매 추 출물은 동맥경화로 인한 병변 또는 혈관염증 인자의 생성을 효과적으로 억제할 수 있음을 확인하였는 바, 동맥경화의 예방 또는 치료용 조성물의 유효 성분으로 사용 되기에 적합하다.
Abstract translation:
的组合物根据本发明人参（人参CA迈耶）病变如动脉硬化预防或含有水果的提取物作为活性成分的治疗的组合物中，人参果重量chulmul是由于动脉粥样硬化 或血管炎性因子，因此适合用作预防或治疗动脉粥样硬化的组合物的活性成分。
-
公开(公告)号：KR1020100060962A
公开(公告)日：2010-06-07
申请号：KR1020080119781
申请日：2008-11-28
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P9/10
CPC classification number: A61K36/258
Abstract: PURPOSE: A prevention/treatment composition for arteriosclerosis containing a ginseng fruit extract is provided to control the generation of blood vessel inflammation or lesion production factors. CONSTITUTION: A prevention/treatment composition for arteriosclerosis contains a ginseng fruit extract as an active ingredient. The ginseng fruit extract is an extract obtained by drying the pulp and rind of a ginseng fruit and adding a solvent. The ginseng fruit extract contains protopanaxatriol based ginsenoside and protopanaxadiol based ginsenoside in the content rate of 0.5~3.2. The composition contains 0.01~100wt% of ginseng fruit extract which can reduce the generation of affected tissues due to arteriosclerosis, and the production of the blood vessel inflammation factor.
Abstract translation: 目的：提供含有人参果实提取物的动脉硬化预防/治疗组合物，用于控制血管炎症或病变生成因子的产生。 构成：用于动脉硬化的预防/治疗组合物含有人参水果提取物作为活性成分。 人参水果提取物是通过干燥人参果实的果肉和果皮并加入溶剂获得的提取物。 人参果实提取物含有原人参三醇基人参皂苷和原人参二醇基人参皂苷，含量为0.5〜3.2。 该组合物含有0.01〜100wt％的人参果实提取物，可以减少由于动脉硬化引起的受影响组织的产生，并产生血管炎症因子。
-
公开(公告)号：KR101743489B1
公开(公告)日：2017-06-05
申请号：KR1020160009263
申请日：2016-01-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A23L1/30
Abstract: 본발명은인삼열매추출물을유효성분으로함유하는혈행촉진용조성물, 혈관노화방지용조성물, 혈관염증치료용조성물, 혈관생성촉진용조성물, 허혈성심질환치료용조성물및 국부혈류부족개선및 치료용조성물에관한발명으로서, 더욱상세하게는, 인삼열매추출물을유효성분으로함유하여혈관내피세포에서일산화질소(NO)생성을촉진시키고, 혈관내피세포의생존을증진시키며, 혈관내피세포의이동성증가와혈관튜브생성을통한혈관신생을촉진시키는조성물에관한발명이다.
-
公开(公告)号：KR1020140097097A
公开(公告)日：2014-08-06
申请号：KR1020140092769
申请日：2014-07-22
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P7/00 , A61P17/00
Abstract: The present invention relates to a composition containing a ginseng berry extract as an active ingredient for facilitation of blood circulation, prevention of vascular aging, treatment of vascular inflammation, facilitation of angiogenesis, treatment of ischemic heart disease, and improvement and treatment of local blood circulation insufficiency. More specifically, the present invention relates to a composition containing ginseng berry extract as an active ingredient to promote nitric oxide (NO) generation in endothelial cells, improve viability of endothelial cells, and promote angiogenesis through increased mobility of endothelial cells and vascular tube formation.
Abstract translation: 本发明涉及含有人参浆果提取物作为促进血液循环，预防血管老化，血管发生的治疗，促进血管生成，治疗缺血性心脏病以及改善和治疗局部血液循环的活性成分的组合物 功能不全。 更具体地，本发明涉及含有人参浆果提取物作为活性成分的组合物，以促进内皮细胞中的一氧化氮（NO）产生，提高内皮细胞的活力，并通过增加内皮细胞的活动性和血管形成来促进血管生成。
-
公开(公告)号：KR1020150007272A
公开(公告)日：2015-01-20
申请号：KR1020140182213
申请日：2014-12-17
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P9/10 , A61P9/00
Abstract: The present invention relates to a composition for promoting blood circulation, a composition for preventing vascular aging, a composition for treating vascular inflammation, a composition for promoting angiogenesis, a composition for treating ischemic heart disease, and a composition for alleviating and treating regional blood supply shortage, which contain a ginseng berry extract as an active ingredient and, more specifically, to a composition which contains a ginseng berry extract as an active ingredient, thereby promoting nitrogen monoxide (NO) generation in vascular endothelial cells, improving survival rate of vascular endothelial cells, and promoting angiogenesis through an increase in migration of vascular endothelial cells and the generation of vascular tubes.
Abstract translation: 本发明涉及用于促进血液循环的组合物，用于预防血管老化的组合物，用于治疗血管炎症的组合物，用于促进血管发生的组合物，用于治疗缺血性心脏病的组合物和用于缓解和治疗局部血液供应的组合物 其中含有人参浆果提取物作为活性成分，更具体地说，涉及含有作为活性成分的人参浆果提取物的组合物，从而促进血管内皮细胞中的一氧化氮（NO）产生，提高血管内皮细胞存活率 细胞，并通过增加血管内皮细胞的迁移和血管管的产生来促进血管生成。
-
Patent Agency Ranking
公开(公告)号：KR1020080104600A
公开(公告)日：2008-12-03
申请号：KR1020070051593
申请日：2007-05-28
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P9/10 , A61P19/02
CPC classification number: A61K36/258 , A23L33/105 , A23V2002/00 , A61K9/0019 , A61K9/0095 , A61K9/1652 , A61K9/2018 , A61K9/4875 , A61K31/198 , A23V2250/2124 , A23V2200/318 , A23V2200/326 , A61K2300/00
Abstract: A composition for promoting the blood circulation is provided to promote the blood circulation by expanding the blood vessel and to inhibit the aging of the blood vessel. A composition for promoting the blood circulation contains an extract of the fruit of insam (ginseng) as an effective ingredient. Preferably the extract of the fruit of insam is prepared by adding ethanol to the dried one of insam fruit to reflux it for extraction, and filtering and concentrating the obtained extract; and removing the oil-soluble component, adding butanol to it to extract it, and concentrating the obtained extract.
Abstract translation: 提供促进血液循环的组合物，以通过扩张血管来促进血液循环，并抑制血管的老化。 用于促进血液循环的组合物含有作为有效成分的insam（人参）水果的提取物。 优选地，通过将乙醇加入到干燥的塞米果中以回流以提取来制备insam果实的提取物，并过滤并浓缩所得提取物; 除去油溶性成分，向其中加入丁醇进行萃取，浓缩得到的提取物。
-
公开(公告)号：KR101647654B1
公开(公告)日：2016-08-11
申请号：KR1020140092769
申请日：2014-07-22
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P7/00 , A61P17/00
Abstract: 본발명은인삼열매추출물을유효성분으로함유하는혈행촉진용조성물, 혈관노화방지용조성물, 혈관염증치료용조성물, 혈관생성촉진용조성물, 허혈성심질환치료용조성물및 국부혈류부족개선및 치료용조성물에관한발명으로서, 더욱상세하게는, 인삼열매추출물을유효성분으로함유하여혈관내피세포에서일산화질소(NO)생성을촉진시키고, 혈관내피세포의생존을증진시키며, 혈관내피세포의이동성증가와혈관튜브생성을통한혈관신생을촉진시키는조성물에관한발명이다.
-
公开(公告)号：KR101614110B1
公开(公告)日：2016-04-21
申请号：KR1020080119781
申请日：2008-11-28
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P9/10
CPC classification number: A61K36/258
Abstract: 본발명에따른조성물은인삼(Panax ginseng C.A. Meyer) 열매의추출물을유효성분으로함유하는동맥경화예방또는치료용조성물로서, 상기인삼열매추출물은동맥경화로인한병변또는혈관염증인자의생성을효과적으로억제할수 있음을확인하였는바, 동맥경화의예방또는치료용조성물의유효성분으로사용되기에적합하다.
-
公开(公告)号：KR1020160022838A
公开(公告)日：2016-03-02
申请号：KR1020160009263
申请日：2016-01-26
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A23L1/30
Abstract: 본발명은인삼열매추출물을유효성분으로함유하는혈행촉진용조성물, 혈관노화방지용조성물, 혈관염증치료용조성물, 혈관생성촉진용조성물, 허혈성심질환치료용조성물및 국부혈류부족개선및 치료용조성물에관한발명으로서, 더욱상세하게는, 인삼열매추출물을유효성분으로함유하여혈관내피세포에서일산화질소(NO)생성을촉진시키고, 혈관내피세포의생존을증진시키며, 혈관내피세포의이동성증가와혈관튜브생성을통한혈관신생을촉진시키는조성물에관한발명이다.
Abstract translation: 本发明涉及：用于促进血液循环的组合物; 用于血管抗衰老的组合物; 用于治疗血管炎症的组合物; 用于促进血管发生的组合物; 用于治疗缺血性心脏病的组合物; 以及用于减轻和治疗局部血液缺乏的组合物，其中所述组合物包含人参浆果提取物作为活性成分，更具体地，涉及通过将人参浆果提取物作为活性成分促进血管内皮细胞中的一氧化氮产生的组合物 成分，增强血管内皮细胞的存活，并通过血管内皮细胞的移动性增加和血管管生成促进血管生成。
-
公开(公告)号：KR101484862B1
公开(公告)日：2015-01-22
申请号：KR1020130155424
申请日：2013-12-13
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P9/00 , A61P29/00
Abstract: 본 발명은 인삼열매 추출물을 유효성분으로 함유하는 혈행촉진용 조성물, 혈관노화방지용 조성물, 혈관염증치료용 조성물, 혈관생성촉진용 조성물, 허혈성 심질환 치료용 조성물 및 국부 혈류부족 개선 및 치료용 조성물에 관한 발명으로서, 더욱 상세하게는, 인삼열매 추출물을 유효성분으로 함유하여 혈관내피세포에서 일산화질소(NO)생성을 촉진시키고, 혈관내피세포의 생존을 증진시키며, 혈관내피세포의 이동성 증가와 혈관튜브생성을 통한 혈관신생을 촉진시키는 조성물에 관한 발명이다.
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.024 seconds)
